Year archive

ACTINOGEN MEDICAL LIMITED — 2024 filings

All 115 regulatory filings released by ACTINOGEN MEDICAL LIMITED (ACW) in 2024, sourced directly from the official regulator.

115 Filings

2024 Period

2024 filings (115)

Filing	Released	Lang
Change in substantial holding 6 pages 161.8KB Major Shareholding Notification	2024-12-18	English
Application for quotation of securities - ACW 7 pages 20.9KB Share Issue/Capital Change	2024-12-15	English
Application for quotation of securities - ACW 7 pages 22.0KB Share Issue/Capital Change	2024-12-12	English
Listed Options Top 20 & Distribution Schedule 4 pages 140.5KB Major Shareholding Notification	2024-12-12	English
ACW to list $0.05 options exp 31 May 2027 - ASX code ACWOD 3 pages 252.7KB Capital/Financing Update	2024-12-12	English
ACW randomizes first US participant in Alzheimers trial 3 pages 254.9KB Regulatory Filings	2024-12-08	English
Application for quotation of securities - ACW 6 pages 18.2KB Share Issue/Capital Change	2024-12-04	English
Notification of cessation of securities - ACW 4 pages 14.8KB Share Issue/Capital Change	2024-12-02	English
Notification of cessation of securities - ACW 4 pages 14.8KB Transaction in Own Shares	2024-11-27	English
Actinogen 2024 AGM, Chairs address and CEOs presentation 25 pages 1.8MB AGM Information	2024-11-13	English
Results of Annual General Meeting 3 pages 244.6KB Declaration of Voting Results & Voting Rights Announcements	2024-11-13	English
Actinogen receives $9.0 million R&D tax incentive rebate 2 pages 223.4KB Capital/Financing Update	2024-11-11	English
Notification of buy-back - ACW 5 pages 15.0KB Transaction in Own Shares	2024-11-05	English
Results of General Meeting 3 pages 245.0KB Declaration of Voting Results & Voting Rights Announcements	2024-11-03	English
Application for quotation of securities - ACW 7 pages 21.0KB Regulatory Filings	2024-11-03	English
Application for quotation of securities - ACW 7 pages 21.0KB Share Issue/Capital Change	2024-11-03	English
Cleansing Notice 2 pages 322.1KB Capital/Financing Update	2024-11-03	English
Appendix 3Ys x 4 8 pages 342.9KB Director's Dealing	2024-11-03	English
ACW CMO presents academic poster at CTAD 2024 conference 4 pages 602.4KB Regulatory Filings	2024-10-30	English
ACW September 2024 quarterly activity report & Appendix 4C 8 pages 613.8KB Interim / Quarterly Report Q1 2024	2024-10-29	English
Actinogen appoints Andrew Udell as Chief Commercial Officer 3 pages 249.6KB Board/Management Information	2024-10-28	English
Issue of SPP shares & attaching listed options following GM 3 pages 226.2KB Capital/Financing Update	2024-10-28	English
ACW Dementia Trials Australia presentation 28 pages 1.9MB Investor Presentation	2024-10-10	English
Letter to Shareholders, Notice of AGM & Proxy Form 20 pages 656.5KB AGM Information	2024-10-10	English
Annual Report to Shareholders 78 pages 6.8MB Regulatory Filings	2024-10-10	English
$3.0 million share purchase plan closes 1.3x oversubscribed 3 pages 259.6KB Capital/Financing Update	2024-10-09	English
Letter to Shareholders & Notice of General Meeting 24 pages 661.5KB Proxy Solicitation & Information Statement	2024-10-03	English
Change in substantial holding 2 pages 165.7KB Major Shareholding Notification	2024-09-25	English
Date of AGM and Closing Date for Director Nominations 2 pages 220.0KB AGM Information	2024-09-24	English
Application for quotation of securities - ACW 6 pages 18.5KB Share Issue/Capital Change	2024-09-23	English
Cleansing Notice 2 pages 322.0KB Capital/Financing Update	2024-09-23	English
Update - Application for quotation of securities - ACW 6 pages 18.2KB Share Issue/Capital Change	2024-09-23	English
Letter to Eligible Shareholders 4 pages 287.4KB Capital/Financing Update	2024-09-23	English
Letter to Ineligible Shareholders 2 pages 224.1KB Capital/Financing Update	2024-09-23	English
Application for quotation of securities - ACW 7 pages 22.4KB Share Issue/Capital Change	2024-09-23	English
Listed Options Distribution Schedule 1 page 71.3KB Major Shareholding Notification	2024-09-23	English
Listed Options Top 20 Holders 2 pages 85.1KB Major Shareholding Notification	2024-09-23	English
Share Purchase Plan & Options Prospectus 42 pages 661.8KB Capital/Financing Update	2024-09-19	English
Actinogen CEO presents at Pitt Street Research Conference 34 pages 1.9MB Investor Presentation	2024-09-18	English
ACW $11.1m capital raising to accelerate Alzheimers trial 50 pages 2.0MB Capital/Financing Update	2024-09-17	English
Proposed issue of securities - ACW 6 pages 21.6KB Capital/Financing Update	2024-09-17	English
Proposed issue of securities - ACW 6 pages 22.0KB Capital/Financing Update	2024-09-17	English
Proposed issue of securities - ACW 8 pages 27.1KB Capital/Financing Update	2024-09-17	English
Pause in Trading 1 page 118.6KB Regulatory Filings	2024-09-15	English
Trading Halt 2 pages 684.4KB Capital/Financing Update	2024-09-15	English
Application for quotation of securities - ACW 6 pages 18.2KB Share Issue/Capital Change	2024-09-10	English
Application for quotation of securities - ACW 6 pages 18.2KB Share Issue/Capital Change	2024-09-04	English
ACW Appendix 4E and 2024 Annual Report 82 pages 6.6MB Regulatory Filings	2024-08-29	English
ACW FY2024 results, advancing into late-stage trials 4 pages 278.2KB Annual Report FY 2024	2024-08-29	English
Corporate Governance Statement 16 pages 478.8KB Governance Information	2024-08-29	English
Appendix 4G 13 pages 389.2KB Regulatory Filings	2024-08-29	English
ACW updated positive depression trial results presentation 30 pages 1.6MB Investor Presentation	2024-08-28	English
ACW updated depression trial results and implications 4 pages 280.7KB Regulatory Filings	2024-08-25	English
Application for quotation of securities - ACW 7 pages 21.1KB Share Issue/Capital Change	2024-08-12	English
ACW XanaCIDD phase 2a trial topline results 27 pages 1.4MB Regulatory Filings	2024-08-11	English
Trading Halt 2 pages 688.5KB Regulatory Filings	2024-08-07	English
Application for quotation of securities - ACW 8 pages 24.0KB Share Issue/Capital Change	2024-07-30	English
ACW CMO presents academic poster at AAIC in Philadelphia 4 pages 2.7MB Regulatory Filings	2024-07-28	English
Application for quotation of securities - ACW 7 pages 21.1KB Share Issue/Capital Change	2024-07-24	English
Application for quotation of securities - ACW 7 pages 21.1KB Share Issue/Capital Change	2024-07-23	English
ACW June 2024 quarterly activity report & Appendix 4C 8 pages 641.5KB Interim / Quarterly Report Q4 2024	2024-07-21	English
Application for quotation of securities - ACW 7 pages 21.1KB Share Issue/Capital Change	2024-07-18	English
Application for quotation of securities - ACW 7 pages 21.1KB Share Issue/Capital Change	2024-07-17	English
Application for quotation of securities - ACW 7 pages 21.1KB Share Issue/Capital Change	2024-07-16	English
Application for quotation of securities - ACW 8 pages 24.0KB Share Issue/Capital Change	2024-07-09	English
Results of Meeting 3 pages 243.5KB Declaration of Voting Results & Voting Rights Announcements	2024-07-08	English
Application for quotation of securities - ACW 6 pages 18.3KB Share Issue/Capital Change	2024-07-04	English
Application for quotation of securities - ACW 8 pages 24.0KB Share Issue/Capital Change	2024-07-03	English
ACW XanaCIDD depression trial results expected early August 3 pages 265.6KB Regulatory Filings	2024-07-01	English
Positive Xanamem biomarker trial published in Jnl Alz Dis 4 pages 340.3KB Regulatory Filings	2024-06-25	English
Application for quotation of securities - ACW 7 pages 20.3KB Share Issue/Capital Change	2024-06-16	English
Appendix 3Ys x 5 10 pages 378.2KB Director's Dealing	2024-06-06	English
Letter to Shareholders, Notice of GM & Proxy Form 16 pages 573.9KB Proxy Solicitation & Information Statement	2024-06-06	English
ACW Oversubscribed $3.9 million entitlement offer completed 3 pages 236.6KB Capital/Financing Update	2024-06-04	English
Application for quotation of securities - ACW 6 pages 18.4KB Share Issue/Capital Change	2024-06-04	English
Notification regarding unquoted securities - ACW 5 pages 16.9KB Share Issue/Capital Change	2024-06-04	English
ACW poster presentation at ADRF conference 2024 4 pages 1.1MB Investor Presentation	2024-06-02	English
Actinogen entitlement offer closed and oversubscribed 3 pages 254.9KB Capital/Financing Update	2024-05-29	English
ACW Clinical Trials Science Forum slides & registration 34 pages 2.3MB Investor Presentation	2024-05-22	English
Change in substantial holding 3 pages 166.9KB Major Shareholding Notification	2024-05-15	English
ACWs $3.9m entitlement offer opens & letters distribute 9 pages 607.2KB Capital/Financing Update	2024-05-14	English
Application for quotation of securities - ACW 6 pages 18.6KB Capital/Financing Update	2024-05-13	English
Cleansing Notice 1 page 244.7KB Capital/Financing Update	2024-05-13	English
Notification regarding unquoted securities - ACW 6 pages 20.5KB Share Issue/Capital Change	2024-05-13	English
ACW Clinical Trials Science Forum 23 May registration detail 3 pages 239.8KB Regulatory Filings	2024-05-12	English
Application for quotation of securities - ACW 6 pages 18.3KB Share Issue/Capital Change	2024-05-07	English
Prospectus - Non-renounceable Entitlement Offer 44 pages 704.4KB Capital/Financing Update	2024-05-06	English
ACW lodges Prospectus for entitlement offer of up to $3.9m 4 pages 284.6KB Capital/Financing Update	2024-05-06	English
Actinogen announces capital raising of up to $8.9 million 35 pages 3.0MB Capital/Financing Update	2024-05-02	English
Proposed issue of securities - ACW 11 pages 37.2KB Capital/Financing Update	2024-05-02	English
Trading Halt 2 pages 348.7KB Capital/Financing Update	2024-04-30	English
ACW March 2024 quarterly activity report & Appendix 4C 9 pages 485.2KB Interim / Quarterly Report Q1 2024	2024-04-29	English
ACW completes cognition & depression phase 2 trial enrolment 3 pages 260.7KB Regulatory Filings	2024-04-21	English
Notification of cessation of securities - ACW 4 pages 14.8KB Regulatory Filings	2024-04-14	English
First patient treated in ACW XanaMIA ph 2b Alzheimers trial 3 pages 252.9KB Capital/Financing Update	2024-04-14	English
Notification of cessation of securities - ACW 4 pages 14.8KB Regulatory Filings	2024-04-04	English
Appendix 3Y-Mr Malcolm McComas 2 pages 219.2KB Director's Dealing	2024-04-04	English
Application for quotation of securities - ACW 7 pages 20.2KB Share Issue/Capital Change	2024-04-02	English
ACW corporate presentation revised licensing slide 3 pages 407.6KB Investor Presentation	2024-03-24	English
Actinogen corporate presentation March 2024 33 pages 3.5MB Investor Presentation	2024-03-19	English
Notification of buy-back - ACW 5 pages 15.0KB Transaction in Own Shares	2024-03-19	English
ACW XanaCIDD depression trial enters final enrolment phase 3 pages 256.9KB Regulatory Filings	2024-03-06	English
Application for quotation of securities - ACW 6 pages 18.3KB Share Issue/Capital Change	2024-03-06	English
Actinogen CMO presents at ADPD 2024 conference 4 pages 547.6KB Capital/Financing Update	2024-03-05	English
Actinogen HY2024 financial report and Appendix 4D 26 pages 3.2MB Regulatory Filings	2024-02-25	English
Actinogen HY2024 financial results two key phase 2 trial 4 pages 275.7KB Interim / Quarterly Report H1 2024	2024-02-25	English
Application for quotation of securities - ACW 7 pages 21.1KB Share Issue/Capital Change	2024-02-20	English
Response to ASX Aware Query 8 pages 989.9KB Regulatory Filings	2024-02-19	English
Application for quotation of securities - ACW 7 pages 21.1KB Share Issue/Capital Change	2024-02-15	English
Actinogen awarded UK Innovation Passport for Xanamem 3 pages 257.9KB Regulatory Filings	2024-02-14	English
Application for quotation of securities - ACW 7 pages 20.7KB Share Issue/Capital Change	2024-02-08	English
Notification of cessation of securities - ACW 4 pages 23.8KB Regulatory Filings	2024-01-31	English
ACW December 2023 quarterly activity report & Appendix 4C 8 pages 424.0KB Interim / Quarterly Report Q2 2024	2024-01-29	English
Positive Xanamem brain PET study peer-reviewed publication 3 pages 295.4KB Regulatory Filings	2024-01-23	English
ACW CEO & CMO present at Sachs Neuroscience Innovation Forum 31 pages 2.5MB Investor Presentation	2024-01-07	English

Filings by year

2026 46 filings
2025 62 filings
2024 115 filings
2023 69 filings
2022 63 filings
2021 63 filings
2020 50 filings
2019 50 filings
2018 87 filings
2017 68 filings
2016 39 filings
2015 66 filings
2014 50 filings
2013 57 filings
2012 54 filings
2011 39 filings
2010 27 filings
2009 20 filings
2008 29 filings
2007 17 filings